Quality of life in patients with irritable bowel syndrome.
about
Aspects of the non-pharmacological treatment of irritable bowel syndromePhysiological underpinnings of irritable bowel syndrome: neurohormonal mechanismsFood allergy in irritable bowel syndrome: The case of non-celiac wheat sensitivityThe Gastrointestinal Pain Pointer: A Valid and Innovative Method to Assess Gastrointestinal Symptoms.Digestive Symptoms in Healthy People and Subjects With Irritable Bowel Syndrome: Validation of Symptom Frequency Questionnaire.The effects of cognitive behavioral therapy and drug therapy on quality of life and symptoms of patients with irritable bowel syndrome.Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine.Microbiome restoration diet improves digestion, cognition and physical and emotional wellbeing.Psychological morbidity of celiac disease: A review of the literature.Possible etiology of improvements in both quality of life and overlapping gastroesophageal reflux disease by proton pump inhibitor treatment in a prospective randomized controlled trial.Illness perceptions mediate the relationship between bowel symptom severity and health-related quality of life in IBS patients.Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.Psychiatric, somatic and other functional gastrointestinal disorders in patients with irritable bowel syndrome at a tertiary care centerEffect of composite yogurt enriched with acacia fiber and Bifidobacterium lactisRandomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea-predominant IBS.Burden of constipation-predominant irritable bowel syndrome (IBS-C) in France, Italy, and the United Kingdom.Response of irritable bowel syndrome with constipation patients administered a combined quebracho/conker tree/M. balsamea Willd extract.The Effects of Bariatric Procedures on Bowel HabitReview article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome.Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis.Treatment of abdominal pain in irritable bowel syndrome.Psychological Factors Influence the Irritable Bowel Syndrome and Their Effect on Quality of Life among Firefighters in South KoreaAssessment of the effectiveness and safety of ethosuximide in the treatment of abdominal pain related to irritable bowel syndrome - IBSET: protocol of a randomised, parallel, controlled, double-blind and multicentre trial.Targeting Histamine Receptors in Irritable Bowel Syndrome: A Critical Appraisal.Intolerance to environmental chemicals and sounds in irritable bowel syndrome: Explained by central sensitization?[Visceral pain].Do Effects on Bowel Patterns Imposed by Solifenacin Always Have Negative Impacts on Treating Patients with Overactive Bladder (OAB)?Gastrointestinal Symptoms and FODMAP Intake of Aged-Care Residents from Christchurch, New Zealand.Improving clinical care for patients with irritable bowel syndrome.The impact of irritable bowel syndrome on daily functioning: Characterizing and understanding daily consequences of IBS.Irritable bowel syndrome-type symptoms in female patients with mild systemic lupus erythematosus: frequency, related factors and quality of life.A double blind, placebo-controlled, randomized clinical trial that breast milk derived-Lactobacillus gasseri BNR17 mitigated diarrhea-dominant irritable bowel syndrome.[Food Allergy and Intolerance : Distinction, Definitions and Delimitation].Depressive symptoms in patients with irritable bowel syndrome: a meta-analysis of comparative studies
P2860
Q26777536-A9D632EE-2D10-4120-A8D5-84BCD7A7DECFQ26830683-ECE61E89-5CC2-4DAA-AB12-9AACBF788679Q28087731-209C8EA1-14A1-48F8-86B9-4A3754FEDA88Q30488670-ED4EE8EF-6C19-452C-8792-091C4343CB2AQ33462226-E94939AF-11E6-4729-8F06-32FC9B88B32CQ33635500-3FBE48CB-7CFF-4D13-8A77-BCC89CBB0E8AQ33668232-4BE8604F-6CFE-4F58-9430-DF6287615E37Q33797465-068CD444-5B36-4F9F-BB56-E7B374DD828BQ34474144-757EE5E5-535D-4E03-86C7-B46D2E7C0C5CQ35003407-D92BD6C0-EC8A-407C-AB5B-1ADCCBD40F71Q35825279-64AB55E7-D461-4B51-9A03-9EFF9E5F14AEQ35843069-9B2353F1-2FB0-4984-8C97-988463681240Q36105443-BEA02277-9896-4F82-B33F-865469E85A38Q36214586-8CAF19E2-3D69-4E43-9203-6EE2A337B637Q36297736-F1436F9D-6844-4BCF-83C2-280094460577Q36401806-EEDBB545-3AEA-4E47-91E2-F666DCF9DFCFQ37178740-45BAC012-4A27-4B86-88CF-105B4645C3ECQ37245905-0998F440-9018-47B2-99EB-0596D892ED1CQ38052154-034648F5-4D99-4498-971F-8992F7685845Q38209378-E4DD6216-F8D6-49E3-9FC1-0E7AC6A97CFCQ38213185-D336958D-818D-4F83-9547-D43D7FF6B116Q38606287-0831E3C3-1E96-4ACE-81F3-31D4721D5779Q39152683-855DA4A6-F31D-45C0-9B06-61DD9990D83DQ39334633-FDE318F1-1776-4259-BB9B-287C1181E933Q39624581-3CFCA07F-B7E8-43BE-A416-48A859548A62Q41484472-800F9A95-15EF-48D0-9DD0-41496125F36FQ43348281-15D4548D-035D-4896-93CD-2CEB18D76BECQ47151388-CE28F97C-2FBA-4E71-BAEA-451E527276F1Q47450300-B365CA7E-2E7A-46A9-88FE-A88D06D7E631Q48038126-620F9B86-9B24-4622-B191-EB0B4838C133Q48154781-C97A89E6-993A-4E6B-ABD4-703F98837225Q52333950-1E7F52D3-9975-483E-8C55-19573722D846Q52851998-FB4E3719-59E3-46AE-853B-AC2E1EEFD857Q58775825-0E06019F-A75E-48B0-BE2A-697FA16F680B
P2860
Quality of life in patients with irritable bowel syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Quality of life in patients with irritable bowel syndrome.
@en
Quality of life in patients with irritable bowel syndrome.
@nl
type
label
Quality of life in patients with irritable bowel syndrome.
@en
Quality of life in patients with irritable bowel syndrome.
@nl
prefLabel
Quality of life in patients with irritable bowel syndrome.
@en
Quality of life in patients with irritable bowel syndrome.
@nl
P1476
Quality of life in patients with irritable bowel syndrome.
@en
P304
P356
10.1097/MCG.0B013E31821FBF44
P478
P577
2011-08-01T00:00:00Z